BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3398837)

  • 1. Cardiac lipoprotein lipase: effects of lipopolysaccharide and tumor necrosis factor.
    Hülsmann WC; Dubelaar ML; De Wit LE; Persoon NL
    Mol Cell Biochem; 1988 Feb; 79(2):137-45. PubMed ID: 3398837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
    Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-decasaccharides impair the catabolism of chylomicrons.
    Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):437-44. PubMed ID: 8973550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial lipopolysaccharide suppresses the expression of lipoprotein lipase in murine macrophages: a process independent of tumor necrosis factor or interleukin 1.
    Sopher O; Goldman R
    Immunol Lett; 1987 Jul; 15(3):261-5. PubMed ID: 3499389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice.
    Feingold KR; Marshall M; Gulli R; Moser AH; Grunfeld C
    Arterioscler Thromb; 1994 Nov; 14(11):1866-72. PubMed ID: 7947614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase is nitrated in vivo after lipopolysaccharide challenge.
    Casanovas A; Carrascal M; Abián J; López-Tejero MD; Llobera M
    Free Radic Biol Med; 2009 Dec; 47(11):1553-60. PubMed ID: 19715756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
    Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart.
    Wu G; Zhang L; Gupta J; Olivecrona G; Olivecrona T
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E908-15. PubMed ID: 17595214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic fate of rat heart endothelial lipoprotein lipase.
    Chajek-Shaul T; Bengtsson-Olivecrona G; Peterson J; Olivecrona T
    Am J Physiol; 1988 Sep; 255(3 Pt 1):E247-54. PubMed ID: 3421325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor.
    Friedman G; Gallily R; Chajek-Shaul T; Stein O; Shiloni E; Etienne J; Stein Y
    Biochim Biophys Acta; 1988 May; 960(2):220-8. PubMed ID: 3284593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal response of lipoprotein lipase-suppressing mediator and tumor necrosis factor in lipopolysaccharide -injected and -infused rats.
    Bagby GJ; Thompson JJ; Wilson LA; Hazel RM
    Circ Shock; 1989 Aug; 28(4):385-94. PubMed ID: 2673573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B; Spooner M; Severson DL
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial lipopolysaccharide reduces macrophage lipoprotein lipase levels: an effect that is independent of tumor necrosis factor.
    White JR; Chait A; Klebanoff SJ; Deeb S; Brunzell JD
    J Lipid Res; 1988 Oct; 29(10):1379-85. PubMed ID: 3235920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
    Braun JE; Severson DL
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
    Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
    Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is involved.
    Wu G; Brouckaert P; Olivecrona T
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E711-7. PubMed ID: 14693508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
    Carroll R; Juhasz A; Severson DL
    Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.